Association between Dietary Vitamin C Intake and Risk of Prostate Cancer: A Meta-analysis Involving 103,658 Subjects

We attempted to systematically determine the association between dietary intake of vitamin C and risk of prostate cancer. PubMed and Embase were searched to obtain eligible studies published before February 2015.

Cohort or case-control studies that reported the relative risk (RR)/odds ratio (OR) estimates with 95% confidence intervals (CIs) for the association between vitamin C intake and prostate cancer risk were included. Eighteen studies regarding dietary vitamin C intake were finally obtained, with a total of 103,658 subjects. The pooled RR of prostate cancer for the highest versus the lowest categories of dietary vitamin C intake was 0.89 (95%CI: 0.83-0.94; p = 0.000) with evidence of a moderate heterogeneity (I(2) = 39.4%, p = 0.045). Meta-regression analysis suggested that study design accounted for a major proportion of the heterogeneity. Stratifying the overall study according to study design yielded pooled RRs of 0.92 (95%CI: 0.86-0.99, p = 0.027) among cohort studies and 0.80 (95%CI: 0.71-0.89, p = 0.000) among case-control studies, with no heterogeneity in either subgroup. In the dose-response analysis, an inverse linear relationship between dietary vitamin C intake and prostate cancer risk was established, with a 150 mg/day dietary vitamin C intake conferred RRs of 0.91 (95%CI: 0.84-0.98, p = 0.018) in the overall studies, 0.95 (95%CI: 0.90-0.99, p = 0.039) in cohort studies, and 0.79 (95%CI: 0.69-0.91, p = 0.001) in case-control studies. In conclusion, intake of vitamin C from food was inversely associated with prostate cancer risk in this meta-analysis.

Journal of Cancer 2015 Jul 28*** epublish ***

Xiao-Yan Bai, Xinjian Qu, Xiao Jiang, Zhaowei Xu, Yangyang Yang, Qiming Su, Miao Wang, Huijian Wu

1 School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China , 2 School of Life Science and Medicine, Dalian University of Technology, Panjin, China , 1 School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China , 1 School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China , 1 School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China , 2 School of Life Science and Medicine, Dalian University of Technology, Panjin, China , 1 School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China , 1 School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China ; 2 School of Life Science and Medicine, Dalian University of Technology, Panjin, China

PubMed     Full Text Article

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe